Olema Pharmaceuticals, Inc.
OLMA · NASDAQ
12/31/2024 | 12/31/2023 | 12/31/2022 | 12/31/2021 | |
|---|---|---|---|---|
| Operating Activities | – | – | – | – |
| Net Income | -$129 | -$97 | -$105 | -$71 |
| Dep. & Amort. | $0 | $0 | $2 | $2 |
| Deferred Tax | $0 | $0 | $0 | $0 |
| Stock-Based Comp. | $23 | $17 | $0 | $0 |
| Change in WC | $9 | -$1 | $3 | $3 |
| Other Non-Cash | -$7 | -$4 | $18 | $16 |
| Operating Cash Flow | -$104 | -$84 | -$82 | -$51 |
| Investing Activities | – | – | – | – |
| PP&E Inv. | -$0 | $0 | -$0 | -$2 |
| Net Acquisitions | $0 | $0 | $0 | $0 |
| Inv. Purchases | -$395 | -$256 | -$214 | -$487 |
| Inv. Sales/Matur. | $302 | $251 | $306 | $213 |
| Other Inv. Act. | $0 | $0 | $0 | $0 |
| Investing Cash Flow | -$94 | -$5 | $91 | -$275 |
| Financing Activities | – | – | – | – |
| Debt Repay. | $0 | $0 | $0 | $0 |
| Stock Issued | $266 | $130 | $0 | $1 |
| Stock Repurch. | $0 | $0 | $0 | $0 |
| Dividends Paid | $0 | $0 | $0 | $0 |
| Other Fin. Act. | $3 | $4 | $0 | $0 |
| Financing Cash Flow | $269 | $133 | $0 | $1 |
| Forex Effect | $0 | $0 | $0 | $0 |
| Net Chg. in Cash | $71 | $45 | $10 | -$325 |
| Supplemental Information | – | – | – | – |
| Beg. Cash | $69 | $24 | $14 | $339 |
| End Cash | $139 | $69 | $24 | $14 |
| Free Cash Flow | -$105 | -$84 | -$82 | -$52 |